A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects
Clinical trial NCT06860282 · COMPLETED
Trial details
- NCT number
- NCT06860282
- Sponsor
- Heronova Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-26
- Primary completion
- 2023-03-27
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.